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Organ-on-chip (OOC) systems recapitulate key biological processes and responses
in vitro exhibited by cells, tissues, and organs in vivo. Accordingly, these models of
both health and disease hold great promise for improving fundamental research, drug
development, personalized medicine, and testing of pharmaceuticals, food substances,
pollutants etc. Cells within the body are exposed to biomechanical stimuli, the nature of
which is tissue specific and may change with disease or injury. These biomechanical
stimuli regulate cell behavior and can amplify, annul, or even reverse the response
to a given biochemical cue or drug candidate. As such, the application of an
appropriate physiological or pathological biomechanical environment is essential for
the successful recapitulation of in vivo behavior in OOC models. Here we review
the current range of commercially available OOC platforms which incorporate active
biomechanical stimulation. We highlight recent findings demonstrating the importance of
including mechanical stimuli in models used for drug development and outline emerging
factors which regulate the cellular response to the biomechanical environment. We
explore the incorporation of mechanical stimuli in different organ models and identify
areas where further research and development is required. Challenges associated with
the integration of mechanics alongside other OOC requirements including scaling to
increase throughput and diagnostic imaging are discussed. In summary, compelling
evidence demonstrates that the incorporation of biomechanical stimuli in these OOC
or microphysiological systems is key to fully replicating in vivo physiology in health
and disease.
Keywords: microphysiological systems, organ-on-chip, mechanobiology, biomechanics, biomechanical
stimulation, pre-clinical model, tensile strain, fluid shear
INTRODUCTION
Pre-clinical drug development requires physiologically relevant in vitro models which successfully
recapitulate the human tissue or organ scenario in vivo. These predictive models are also
extremely valuable for fundamental research into health and disease and for testing the response to
manufactured products, food substances, toxins, pollutants, etc., providing potential as platforms
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for personalized medicine. Organ-on-chip (OOC) technology
holds great promise in this regard as it facilitates the design of
biomimetic microfluidic models incorporating multiple cell types
and extracellular matrix (ECM) cues within a 2- or 3-dimensional
(3D) environment, thereby replicating functional units of human
tissues and organs in vitro (Huh et al., 2013; Caplin et al., 2015;
Skardal et al., 2016; Caballero et al., 2017). These OOCs, also
known as microphysiological systems, are increasingly being used
to model both healthy and diseased organs and as drug screening
platforms (Esch et al., 2015). This positions OOC technology
as a potential route toward delivering safer and more effective
treatments and unblocking the drug development pipeline which
currently suffers substantial and costly attrition. As a result,
there is significant interest and investment in this area from the
biotech and pharmaceutical industries. Indeed, it is estimated
that OOC technology could reduce pharmaceutical research and
development costs by 10–26% (Franzen et al., 2019).
Organ-on-chip systems facilitate the application of multiple
biochemical and biomechanical cues which direct cell behavior
and ultimately replicate key aspects of tissue and organ function
(Bhatia and Ingber, 2014). Biomechanical cues influence the
growth and form of practically all tissues in the human body
and are well established as modulators of cell signaling in
health and disease (Jaalouk and Lammerding, 2009). While
biomechanical stimuli can alter mass transport within tissues to
modulate biochemical signaling gradients, cells can also sense
these signals through mechanotransduction. Mechanobiology
is the study of the cellular interpretation of biomechanical
stimuli which, over the past 25 years, has become a burgeoning
field of interdisciplinary research. The fundamental role of
mechanobiology in many physiological processes, including the
response to pharmaceuticals and other stimuli, necessitates the
incorporation of biomechanical cues into OOC systems. For
example, the incorporation of cyclic tensile strain mimicking
lung epithelial stretch while breathing into an OOC lung-on-a-
chip device is crucial to obtaining a physiological inflammatory
response (Huh et al., 2010). The use of microfluidic platforms
such as OOC systems for the study of mechanobiology is
well established (Polacheck et al., 2013), while the innovative
OOC field is producing novel approaches toward incorporating
biomechanical cues into chip design as recently reviewed by
Kaarj and Yoon (2019). However, to satisfy regulators and
ensure reliability, OOC models with application in pre-clinical
research or personalized medicine require standardized systems
with validated biological models. In this review we highlight
some instances where mechanical stimuli can drastically alter a
given biochemical response with relevance to pre-clinical models.
We summarize commercially available OOC model systems
incorporating biomechanical stimuli, and review efforts to utilize
these systems across different anatomical systems. The versatility
of many of these OOC systems facilitates their application toward
multiple organ models in addition to those validated to date, and
we discuss future perspectives for this technology. As the field
looks to build biological complexity in these OOC systems, it
remains to be seen whether it is necessary to precisely mimic
the diverse biomechanical stimuli found in vivo, or whether an
approximation of in vivo biomechanics is sufficient.
MECHANOBIOLOGY AND THE
IMPORTANCE OF BIOMECHANICAL
STIMULI IN OOC
The Nature of Biomechanical Stimuli
In vivo, cells are subjected to combinations of biomechanical
and biochemical stimuli, which can interact to modulate the
cellular response. Biomechanical cues are often extrinsic to the
cell and can take passive or active forms. Passive biomechanical
stimuli include substrate stiffness, geometric confinement, or
topographic cues. Active stimuli include connective tissue tensile
stretch and compression, fluid shear stress, interstitial fluid flow,
and hydrostatic pressure (Figure 1).
While the nature of the biomechanical signal is important,
the cellular response is also heavily dependent on the duration,
magnitude, and frequency of the active biomechanical cue.
Efforts to engineer connective tissues have used biomechanical
signals as drivers of anabolic tissue formation and stem cell
differentiation (Potier et al., 2010; Delaine-Smith and Reilly,
2012). Dynamic compression has long been applied to
chondrocytes (Kim et al., 1994), with physiological loading
duration, magnitude and frequency capable of eliciting
anabolic responses (Anderson and Johnstone, 2017), while
supraphysiological strain rates via high magnitude or frequency
can drive a catabolic response (Leong et al., 2011). Experiments
in fracture healing have demonstrated that mesenchymal stem
cell (MSC) lineage specification can be driven in vivo by both
magnitude and type of biomechanical signal, e.g., interstitial fluid
flow or hydrostatic pressure (McMahon et al., 2008; Lee et al.,
2011). These active stimuli can be further tuned to modulate
stem cell differentiation through their interactions with passive
stimuli such as substrate stiffness (Engler et al., 2006) and cellular
confinement (McBeath et al., 2004; Gao et al., 2010).
An instance where strain magnitude and frequency can have
physiological consequences is in mechanical lung ventilation,
commonly used in very prematurely born infants. Children
who received high frequency oscillatory ventilation as neonates
had superior lung function at 11–14 years than those receiving
conventional mechanical ventilation (Zivanovic et al., 2014).
When the associated strain magnitudes were investigated in vitro
using A549 alveolar analog cells, lower strain amplitudes
associated with high frequency oscillatory ventilation resulted
in a reduced inflammatory response which may provide an
explanation for superior lung function years later (Harris et al.,
2019). A great deal of literature has focused on identifying
appropriate and pathological biomechanical parameters for
specific cell types and tissues, and such studies involving
microphysiological systems relevant to OOC models have been
reviewed by Polacheck et al. (2013) and Kaarj and Yoon (2019).
Mechanobiology Regulates Cell Behavior
and Response to Pharmaceuticals
Biomechanical signals can direct cell behavior in numerous
contexts. Interactions between biomechanical signals can have
unexpected effects, with dynamic compression overriding the
influence of hydrogel substrate to divert MSC differentiation
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FIGURE 1 | Schematic illustration of biomechanical stimuli and examples of how these stimuli could be implemented in organ-on-chip systems. (A–E) Active
biomechanical stimuli including (A) fluid shear stress, (B) interstitial fluid flow, (C) hydrostatic pressure, (D) tensile stretch, and (E) compression. (F–H) Passive
biomechanical stimuli including (F) substrate stiffness, (G) substrate topography, and (H) geometric confinement.
from myogenic to chondrogenic (Thorpe et al., 2012).
Biomechanical signals can also modulate the cellular response
to biochemical signals including pharmaceuticals. For example,
matrix rigidity can switch the functional response to the cytokine
transforming growth factor-β1 (TGF-β1) in epithelial cells, with
TGF-β1 inducing apoptosis in cells on soft substrates in contrast
to epithelial-mesenchymal transition (EMT) in cells on rigid
substrates (Leight et al., 2012). This demonstrates how changes
in tissue mechanics, as often occur in disease, could confound
the cellular response to a given pharmaceutical.
Active biomechanical cues can also switch the cellular
response to pharmaceuticals. We have shown that dynamic
tensile strain applied to cultured cells in 2D using the Flexcell R©
system can regulate chondrocyte response to histone deacetylase
6 (HDAC6) inhibition (Fu et al., 2019). The inflammatory
cytokine interleukin-1β (IL-1β) triggers nitric oxide and
prostaglandin E2 (PGE2) release from articular chondrocytes,
ultimately leading to the destruction of articular cartilage in
disease. Tubacin, a specific inhibitor of the cytoplasmic tubulin
deacetylase HDAC6, is anti-inflammatory and inhibits nitric
oxide and PGE2 release in the absence of tensile strain (Figure 2).
However, the application of biomechanical strain nullifies the
anti-inflammatory effects of tubacin leading to elevated nitric
oxide and PGE2 release (Figure 2). This compound’s efficacy as
an anti-inflammatory agent is dependent on the biomechanical
environment and highlights the need to include mechanical
stimuli in pre-clinical testing.
The importance of biomechanical stimuli in models of
the respiratory system is highlighted by studies demonstrating
the ability of these stimuli to both modify disease behavior
and drug responsiveness. The addition of biomechanical
stimuli to an orthotopic model of human non-small cell lung
carcinoma (NSCLC) decreased the sensitivity of tumor cells to
tyrosine kinase therapy (Hassell et al., 2017). While this study
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FIGURE 2 | Tensile strain blocks the anti-inflammatory effects of tubacin.
Bovine articular chondrocytes cultured in the presence of vehicle or
interleukin-1β (IL-1β) were treated with HDAC6 inhibitor tubacin and/or cyclic
tensile strain of 10% at 0.33 Hz for 24 h using a Flexcell R© FX5000 cell tension
system. (A) Nitrite (nitric oxide) and (B) prostaglandin E2 (PGE2) release. n = 6;
Two-way ANOVA with Sidak pairwise comparisons: *P ≤ 0.033, **P = 0.0011,
***P = 0.0004. Mean ± s.e.m. with individual values overlaid. Data adapted
from Fu et al. (2019) where further details of methods can be obtained.
found application of breathing motions reduced NSCLC cell
proliferation and cluster formation within an Alveolus-Chip, it
also resulted in the downregulation of epidermal growth factor
receptor (EGFR) expression and signaling which ultimately led
to the accumulation of tumor cells resistant to tyrosine kinase
inhibitor mediated growth inhibition (Hassell et al., 2017). This
may explain the high therapeutic resistance observed in regions
of the lung which remain functionally aerated, and further
demonstrates the importance of considering biomechanical
stimuli in pre-clinical models.
Intrinsic Drivers of Biomechanical
Response in OOC
Mechanobiological responses are cell type dependent, and this
is evident as stem cells change their mechanosensitivity with
differentiation (Thorpe et al., 2010). Indeed, cellular sensitivity
to mechanics may fluctuate in response to various intrinsic
factors which act on timescales ranging from seconds for
biomechanical memory (Heo et al., 2015), to years in the case
of aging (Boers et al., 2018). Biomechanical stimuli provide
integral cues to direct cell behavior, however there are several
emerging intrinsic factors which influence the cellular response
on the timescale of a typical study and should be considered
in OOC strategies.
Biomechanical Memory
The response to a given biomechanical stimulus often results
in changes in the cells and ECM that make up the cellular
microenvironment. This in turn alters the biomechanical
stimuli to which cells are exposed. The resulting mechano-
reciprocal relationship between cell and biomechanical
microenvironment is fundamental to tissue development
and remodeling (van Helvert et al., 2018).
In addition, prior exposure to biomechanical stimuli leads to
epigenetic changes determining the transcriptional response to
subsequent stimuli (Downing et al., 2013; Heo et al., 2015; Li et al.,
2017). Thus, the encoding of the history of biomechanical stimuli
as epigenetic marks can lead to a faster more robust response
upon subsequent stimulation or may temporally silence a
genomic reaction to provide a refractory period of biomechanical
unresponsiveness. Furthermore, different cell lineages have well
documented changes in epigenetic state (Atlasi and Stunnenberg,
2017), which may impact cell behavior in response to strain.
Due to both tissue remodeling and epigenetic factors, previous
exposure to biomechanical stimuli influences the response to
repeat stimulation. Hence OOC systems may need to use pre-
stimulated cells or precondition the model with biomechanical
stimuli prior to testing the biological response to an intervention.
Inflammation
Chronic inflammation is associated with the deregulation
of matrix signaling, tissue fibrosis and stiffening. It is well
established that such changes will alter the biomechanical
response of the cell and can influence a cell’s inherent
biomechanical memory (Heo et al., 2015; Nowell et al., 2016).
However, the direct effect of inflammatory signaling upon cellular
mechanosensitivity itself is unclear. Cytokines can influence
actin, focal adhesions, mechanoreceptor expression and primary
cilia (Wann and Knight, 2012; Wang et al., 2018). Indeed,
preconditioning of synoviocytes with inflammatory cytokines
enhances mechanosensitivity (Estell et al., 2017). Therefore, it
may be important to build OOC models that incorporate this
interaction between inflammation and biomechanical stimuli to
accurately predict in vivo behavior.
Time of Day
Cells possess an internal timing system, or circadian rhythm,
allowing synchronization to predictable environmental
fluctuations of the 24 h day/night cycle. This biological
clock enables the temporal compartmentalization of key cell
processes according to the time of day. The recent findings on
Clock regulation of expression of mechanoreceptors Piezo1 and
TRPV4 in bladder cells (Ihara et al., 2017), the body temperature
sensitivity of TRPV4 activation (Gao et al., 2003), and diurnal
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actin dynamics (Hoyle et al., 2017), supports the concept
of circadian fluctuations in mechanosensitivity. In addition,
biomechanical stimulation, particularly in musculoskeletal
tissues, may be important in regulating the clock, such
that alterations in patterns of loading may disrupt clock
function altering cellular behavior. Consequently, there is
increasing suggestion that protocols for applying biomechanical
stimuli via OOC systems should be coordinated around a
physiological diurnal cycle.
Metabolism
Glycolysis and oxidative phosphorylation are the two major
energy producing pathways in the cell. The shift between
these two processes is a driving force in lineage commitment
and environmental adaptation (Folmes and Terzic, 2016).
Cytoskeletal remodeling and cell traction are energetically
dependent upon glycolytic flux (Shiraishi et al., 2015; Hu et al.,
2016), and it has recently been shown that increasing substrate
stiffness leads to the downregulation of glycolysis (Park et al.,
2020). Furthermore, the mechanosensor polycystin-1 has a dual
function as an essential mitochondrial protein (Lin et al., 2018),
together demonstrating direct connectivity of cell metabolism
and mechanosensitivity. The metabolic status of cells within an
OOC system will therefore influence the effect of biomechanical
stimuli on regulating cell function and drug response.
COMMERCIAL ORGAN-ON-CHIP
PLATFORMS INCORPORATING
BIOMECHANICAL STIMULI
Organ-on-chip platforms vary greatly in their design (Figure 3),
however the majority of commercial systems incorporate
microfluidics to supply cells with nutrients and remove waste
materials, thus also providing biomechanical stimuli in the
form of fluid shear and interstitial flow. A small number
of systems can also stimulate cells with mechanical strain
to mimic biological processes such as breathing, peristalsis
or the pumping of blood through the vasculature. Other
systems that apply electrical stimuli have also been developed
(Feric et al., 2019). In this section we summarize several well
established, commercially available OOC model systems that
incorporate biomechanical stimuli (Table 1). In the subsequent
section, we review efforts to validate these systems across
different anatomical systems. We have focused on nine of
the leading manufacturers of OOC technology who not only
supply hardware but focus on the biological development
of these systems.
AlveoliX
The AXLung-on-Chip System is a medium throughput system
which mimics the biomechanical microenvironment of the air-
blood barrier of the human lung (Figure 3A). It has the
footprint of a standard culture plate (127 mm × 85 mm) and
comprises two chips per plate which each have six “alveolar
wells.” These wells are comprised of an ultrathin (3.5 µm), porous
(3 µm diameter pores) alveolar membrane. Lung cells can be
cultured under air-liquid interface (ALI) on the apical side of
the membrane, and endothelial cells cultured on the basal side.
The membrane is cyclically deflected in three dimensions using
a “micro-diaphragm” beneath the membrane which is deflected
by applying negative and positive pressures through an electro-
pneumatic setup. Consequently, this strain (8%, 0.25 Hz) is
transferred to the alveolar membrane in a manner comparable
to that observed in the human lung.
BI/OND
The inCHIPitTM offers a medium throughput organ chip with up
to six cultures running in parallel. Each chip is comprised of two
compartments which can be subjected to flow (1–300 µL/min)
and are connected by a porous membrane. The top channel (fluid
shear: 1.58 × 10−6–2.10 × 10−4 Pa) is open for added flexibility
while the bottom functions as a microfluidic channel (fluid shear:
0.011–9.722 Pa) and can be subjected to cyclic strain (2.5–10%,
1 Hz). It is suitable for the cultivation of complex 3D tissues
(organoids, ex vivo tissue, spheroids, micro tissues) as well as
tissue-tissue interface models.
CNBio
The PhysioMimixTM OOC system uses open-well plates
(standard footprint: 127 mm × 85 mm) which are compatible
with commercial inserts, tissue-specific scaffolds and scaffold-free
cultures for easy scaling and on-boarding of validated or bespoke
model systems. Up to six plates can be used simultaneously
to run multiple independent experiments. This system allows
real-time sampling and supports long-term, automated culture,
refreshing culture media at a rate of 50–5,000 µL/min with
limited user input and are suitable for single-organ, two-organ,
or multi-organ experiments.
Emulate
The “Human Emulation System” platform comprises Organ-
Chips, instrumentation, software, and applications to create
a micro engineered system that replicates human in vivo-
relevant physiology (Figure 3B). The Chip-S1 is composed of
an elastomeric polymer, PDMS, with an upper channel (1 mm
high × 1 mm wide) separated from a parallel lower channel
(0.2 mm high × 1 mm wide) by a thin, flexible, porous (pore
size 7 µm) membrane coated with ECM and lined with human
cells. Multiple cell sources can be used including primary cells
or organoids and the chips support a 3D microenvironment.
The Zoë Cell Culture Module supports the culture of the chips,
application of pressure-driven flow (0–1,000 µL/h, fluid shear:
top channel; 0–0.009 Pa, bottom channel; 0–0.03 Pa) and stretch
(0–12%, 0.01–0.4 Hz). The application of biomechanical forces
(shear stress and tensile strain) and the ECM environment can
be optimized for different organs or tissues to recreate a more
physiological microenvironment.
Kirkstall
The Quasi Vivo R© system is an advanced interconnected cell
culture flow system. It is engineered to provide in vivo like
conditions for cell growth. Available in three configurations
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 5 December 2020 | Volume 8 | Article 602646
fbioe-08-602646 December 4, 2020 Time: 18:52 # 6
Thompson et al. Organ-on-Chip Mechanobiology
Ultra thin alveolar membrane noitomgnihtaerBpihc-no-gnuL
Channel width: 
Outer Channel Width (OC): 100, 200 μm 
Travel Width (T): 50,100 μm 
Slit Spacing (SS): 50, 100 μm 
Slit Width (WS): Variable
Idealised microvascular network (IMN) 
Microvascular network (digitised image) 
©AlveoliX A.G. 
2-Lane Organoplate®  Culture methodologies 
©Emulate Inc. 
©Mimetas B.V. 
©SynVivo Inc.
A 
AlveoliX
B 
Emulate
C 
Mimetas
D 
SynVivo
10 mm 
10 mm 
10 mm 
20 mm 
20 mm 5 μm 
FIGURE 3 | Comparison of commercially available organ-on-chip platforms incorporating a form of active biophysical stimulus. (A) AX12 lung chip based on a
96-well plate format, consisting of two chips supported by a plate, each of which comprise six independent units. The ultrathin membrane (blue) is deflected by
negative pressure inside the basal chip chamber through an integrated micro-diaphragm (gray). Images© Alveolix A.G. (B) The Human Emulation system from
Emulate Inc. comprising organ chips which fit into the PodTM carrier. The ZoëTM culture module controls the rate of flow and stretch for up to 12 chips. The OrbTM
provides the precise mixture of gas, power, and vacuum stretch required by the ZoëTM culture module. Images© Emulate Inc. (C) The 2-lane OrganoplateTM from
Mimetas. Based on a 384-well plate format, it can support 96-individual models. Cells are cultured in/on ECM alongside a perfusion channel created using unique
phase guide technology. Images© Mimetas B.V. (D) SynVivo’s microfluidic chips create an idealized microvascular network to mimic the formation of, and transport
across, tight and gap junctions. Networks can also be created from digitized images to replicate in vivo physiology more accurately. Natural tissue regions can also
be incorporated within the network topology. Images© SynVivo Inc.
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TABLE 1 | Commercially available organ on chip systems with integrated mechanical stimulation.
Company Mechanical stimulation Validated models
AlveoliX
http://www.alveolix.com/
Strain: 10%, 0.16 Hz
Fluid flow: passive
Alveolus: Inflammation, toxicology, fibrosis (Stucki et al., 2015, 2018; Artzy-Schnirman et al., 2019;
Krempaska et al., 2020; Wang et al., 2020)
BI/OND
https://www.gobiond.com/
Strain: 2.5–10%, 0–1 Hz
Fluid flow: 1–300 µL/min
Fluid shear: upper channel:
1.58 × 10−6–2.10 × 10−4 Pa
lower channel: 0.011–9.722 Pa
Heart, midbrain organoid, cancer
CNBio
https://cn-bio.com/
Fluid flow: 50–5,000 µL/min
Fluid shear: dependent on
model
Liver (Domansky et al., 2010; Vinci et al., 2011; Wheeler et al., 2014; Long et al., 2016; Kostrzewski
et al., 2017, 2020; Sarkar et al., 2017; Rowe et al., 2018; Ortega-Prieto et al., 2019; Vacca et al., 2020).
Liver/Intestine (Chen et al., 2017),
Brain, Heart, Kidney, Lung, Pancreas, Skin.
Emulate, Inc.
https:
//www.emulatebio.com/
Strain: 0–12%, 0.01–0.4 Hz
Fluid Flow: 0–1,000 µL/min
Fluid shear: upper channel:
0–0.009 Pa
lower channel: 0–0.03 Pa
Blood-brain barrier (Sances et al., 2018; Park et al., 2019; Vatine et al., 2019)
Blood vessel: Micro vessel (Jain et al., 2016)
Bone marrow (Torisawa et al., 2014, 2016)
Bone: Osteogenic differentiation (Sheyn et al., 2019)
Lung: Small airway (Huh et al., 2010, 2013; Benam et al., 2016a,b; Jain et al., 2016; Henry et al., 2017;
Si et al., 2020)
Lung: Alveolus (Huh et al., 2012; Jain et al., 2018)
Intestine (Kim et al., 2012; Henry et al., 2017; Villenave et al., 2017; Jalili-Firoozinezhad et al., 2018;
Kasendra et al., 2018, 2020; Workman et al., 2018; Grassart et al., 2019)
Kidney: Glomerulus (Musah et al., 2018)
Kidney: Proximal Tubule (Jang et al., 2013; Vriend et al., 2020; Xu et al., 2020)
Liver (Foster et al., 2019; Jang K. J. et al., 2019; Peel et al., 2019)
Neuronal development (Sances et al., 2018)
Kirkstall
https://www.kirkstall.com/
Fluid flow: 75–250 µL/min
Fluid shear: dependent on
model
Blood-brain barrier (Miranda-Azpiazu et al., 2018; Elbakary and Badhan, 2020)
Brain: Mid brain organoids (Berger et al., 2018)
Heart: cardiac tissue (Pagliari et al., 2014)
Intestine (Giusti et al., 2014)
Liver (Ramachandran et al., 2015; Pedersen et al., 2016; Rashidi et al., 2016; Shannahan et al., 2016)
Lung (Chandorkar et al., 2017)
Pancreas/Liver (Faure et al., 2016)
Kidney
Micronit
https://www.micronit.com/
microfluidics/smart-organ-
on-a-chip-platform.html
Fluid shear: 0.01–5 dyne/cm2 Intestine (Kulthong et al., 2020)
Liver (Li et al., 2018)
Pancreas (Navarro-Tableros et al., 2019; Gomez et al., 2020)
Skin, Lung, Bone marrow, Neural or cardiovascular network
Mimetas
https://mimetas.com/
Fluid flow: Gravity driven
leveling
Fluid shear: 0–0.3 Pa
Blood-brain barrier (Wilmer et al., 2016; Koo et al., 2018)
Blood vessel (van Duinen et al., 2017; Beekers et al., 2018; Poussin et al., 2020)
Blood vessel: Angiogenesis (van Duinen et al., 2019)
Breast cancer (Lanz et al., 2017)
Liver (Jang et al., 2015, 2018; Jang M. et al., 2019)
Neural: CNS toxicity (Moreno et al., 2015; Wevers et al., 2018; Bolognin et al., 2019; Kane et al., 2019)
Intestine (Trietsch et al., 2017; Beaurivage et al., 2019)
Kidney: glomerulus (Petrosyan et al., 2019)
Kidney: proximal tubule (Wilmer et al., 2016; Vormann et al., 2018; Vriend et al., 2018, 2020; Schutgens
et al., 2019)
Pancreas (Kramer et al., 2019)
Brain: Glioma,
SynVivo
https://www.synvivobio.com/
Fluid Flow: 10
nL/min–10 µL/min
Fluid shear: 0.001–2 Pa
Blood-brain barrier (Prabhakarpandian et al., 2013; Deosarkar et al., 2015; Tang et al., 2018; Brown
et al., 2019; Da Silva-Candal et al., 2019)
Blood vessel (Silvani et al., 2019)
Blood vessel: Microvascular network (Rosano et al., 2009; Prabhakarpandian et al., 2011; Lamberti
et al., 2013)
Cancer models (Tang et al., 2017; Terrell-Hall et al., 2017; Vu et al., 2019)
Lung (Kolhar et al., 2013; Liu et al., 2019; Soroush et al., 2020)
TissUse
https://www.tissuse.com/en/
Fluid shear: 0.02–2 Pa Multi-tissue models:
Intestine-Liver-Brain-Kidney (Ramme et al., 2019)
Intestine-Liver-Skin-Kidney (Maschmeyer et al., 2015b)
Liver-Brain (Materne et al., 2015)
Liver-Intestine (Maschmeyer et al., 2015a)
Liver-Kidney (Lin et al., 2020)
Liver-Lung (Schimek et al., 2020)
Liver-Pancreatic islets (Bauer et al., 2017)
(Continued)
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TABLE 1 | Continued
Company Mechanical stimulation Validated models
Liver-Skin (Wagner et al., 2013)
Liver-Skin-Vasculature (Maschmeyer et al., 2015a)
Liver-Testis (Baert et al., 2020)
Skin-Lung cancer (Hubner et al., 2018)
Single tissue models:
Blood vessels (Schimek et al., 2013; Maschmeyer et al., 2015b)
Blood vessels: Micro capillaries (Hasenberg et al., 2015)
Bone marrow (Sieber et al., 2018)
Brain (Materne et al., 2015)
Hair follicle biopsies (Atac et al., 2013)
Intestine (Maschmeyer et al., 2015a)
Kidney (Ramme et al., 2019)
Liver (Maschmeyer et al., 2015a; Materne et al., 2015; Bauer et al., 2017)
Lung (Schimek et al., 2020)
Pancreas: Pancreatic islets (Bauer et al., 2017)
Skin (Atac et al., 2013; Maschmeyer et al., 2015a; Schimek et al., 2018)
Testis (Baert et al., 2020)
(QV500, QV600, and QV900) this system is compatible with
coverslips, membranes, barrier models, ALI culture and a range
of 3D scaffolds. The Quasi Vivo R© system uses a peristaltic pump
to create flow (75–250 µL/min).
Micronit
Provide a range of OOC products in a variety of formats. Their
core device is open and re-sealable consisting of a top and
bottom layer completed by a central membrane layer. These
are secured by dedicated and customizable clamps to create
a cell culture platform with separately controllable fluid-flows
above and below (fluid shear: 0.001–0.5 Pa). Microplate formats
with active flow control systems are also offered based on
fully integrated membrane valves and external actuation. Such
solutions are developed and produced in a business-to-business
fashion according to customer specific requirements. The open
formats support sensory integration with focus applied to the
optical sensing of oxygen.
Mimetas
The OrganoPlate R© is a high throughput, microfluidic 3D
cell culture plate capable of supporting up to 96 individual
models concurrently with the footprint of a single 384-well
plate (127 mm × 85 mm) and is available in 2-lane and 3-
lane configurations (Figure 3C). For the 2-lane configuration,
each individual model consists of two channels, a perfusion
channel, and a gel channel, which are uniquely separated
using phase guides rather than a physical membrane barrier.
Tissues can be grown embedded in an ECM gel (lane width
375 µm) or as a perfused tubule (lane width 325 µm)
against the ECM gel (surface area 1 mm2). Continuous
gravity driven pump-free perfusion is provided using a rocker
system to generate bi-directional flow (fluid shear: 0–0.3 Pa).
This technology supports 3D cell culture, up to 3-layer co-
culture, barrier integrity and transport, angiogenesis, and
gradient formation.
SynVivo
Microfluidic chips are functionalized to recreate complex
in vivo like microenvironments including scale, morphology
and hemodynamics along with endothelial barrier function.
They can support a microvascular network that simulates the
circulation inside any tissue with respect to flow, shear and
pressure conditions. These microfluidic chips are available in
several configurations based on the desired geometry and
tissue conditions and include linear channels, bifurcating
channels (comprising in vivo geometries), micro vascular
networks (obtained from in vivo imaging), and idealized
network designs (Figure 3D). Within the idealized network,
a central chamber, flanked by vascularized micro channels,
allows creation of 3D tissue OOC models for real-time studies
of cellular interactions, extravasation, and drug delivery. The
devices include customized micro fabricated pores to allow
communication between the tissue and vascular cells while
maintaining tight and gap junctions between cells. The side-by-
side architecture of the chips allows for development of complex
cellular morphology while maintaining real time visualization
and quantitation of cell-cell and cell-drug interactions. These
models are also customizable with multiple options for channel
size, tissue chamber size, number of chambers, scaffolding, and
barrier design. Various tissue/OOC models have been validated
against in vivo measurements in oncology, neuroscience, and
inflammation studies. A syringe pump or peristaltic pump
provides continuous flow in this system (1 nL/min–100 µL/min,
fluid shear: 0.001–2 Pa).
TissUse
The HUMIMICTM platform is a miniaturized construct that
closely simulates the activity of multiple human organs. The
platform is available in multiple configurations and can support
up to four different organ models simultaneously on a chip
the size of a standard microscope slide. The organ models are
supplied with media and connected by microfluidic channels
(fluid shear: 0.02–2 Pa) supported by an on-chip pump. Cells and
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tissues can be used to emulate biological barriers as well as to
grow spheroidal and matrix-supported cultures.
INCORPORATION OF BIOMECHANICAL
CUES IN OOC MODELS FOR DIFFERENT
ORGAN SYSTEMS
In the following section we outline some of the major biological
systems where mechanical stimulation is well established to
influence tissue function. We outline how different commercial
OOC systems have been used to generate some of the most
developed models of the cardiovascular, intestine, kidney and
respiratory systems, and discuss how the development of
the biology within these are influenced by the mechanical
environment. However, the importance of mechanical stimuli to
tissue development and function goes beyond these anatomical
systems and will be an important component for the development
of many if not all models, for example muscle, skin or
fetal membrane and would similarly be expected to influence
functionality and drug responses.
Cardiovascular Models
The cardiovascular system is subject to various types and levels
of biomechanical stimuli. Within the heart, highly coordinated
contractions of cardiac muscle pump blood into the vessels
of the circulatory system. In the vasculature, endothelial cells
lining the inner surface of the blood vessels are exposed to
shear stress, tensile strain, and changes in hydrostatic pressure
as the result of pulsatile blood flow. These stimuli influence cell
morphology, proliferation and the permeability of the vessel.
Shear stress is the most significant and prominent of these forces
and disruption as a result of altered flow conditions is associated
with disease such as atherosclerosis, thrombosis, and aneurysm
(Chiu and Chien, 2011). In straight regions of arterial trees,
the vascular endothelium experiences laminar blood flow that
provides high and constant pressure (>1.5 Pa). Whereas regions
that branch and curve experience non-uniform, irregular, and
disturbed blood flow and as such shear stress is lower (<0.4 Pa)
(Gomel et al., 2018).
Key features of the cardiovascular system have been replicated
using OOC technology from blood vessel-on-chip models used to
study single vessels or microvasculature, to heart-on-chip models
(Table 1). Drug-induced cardiotoxicity is a critical issue in drug
development. However, the complex environment of mechanical
and electrical stimulation means that while several heart-on-chip
devices have been published, validated models using commercial
systems are limited. Perhaps the most advanced of these is
the Biowire IITM platform from Tara Biosystems, which uses
biomimetic electrical stimulation to examine the functionality
of engineered cardiac tissue (Nunes et al., 2013). This heart-
on-a-chip device gauges contractile activity generated by the
engineered tissue as a measure of tissue function. As this
review focuses on systems which directly apply mechanical
stimulation, this system is not discussed here. For further review
of recent developments in heart-on-a-chip models please see
(Beverung et al., 2020).
Vascular components are a common feature of barrier models
such as blood-brain barrier, liver, kidney, and intestine models.
Disruption of the vascular barrier plays a key role in the onset
and progression of several diseases, thus preventing disruption
or restoring function are attractive targets for drug discovery.
In the Chip-S1 from Emulate Inc., organ-specific epithelial cells
are cultured within the larger upper channel, while endothelial
cells are cultured in the bottom channel. These endothelial cells
proliferate until a continuous channel lining is formed creating a
micro-vessel that represents the supporting microvasculature of
the tissue. This micro-vessel has been used to study neutrophil
adhesion, rolling and intravasation in lung-chip models of
asthma and chronic obstructive pulmonary disease (COPD)
(Benam et al., 2016a,b). At 0.3 Pa, maximum shear stress in
these systems is significantly lower than observed in vivo. More
recently, a developmental aorta-on-chip was constructed on this
platform. The shear stress values were increased to 0.5 Pa using
a generic multichannel peristaltic pump, and together with cyclic
membrane stretching (10%, 2 Hz) to replicate the heart rate at
this stage of development (∼120 beats per minute), promoted
hematopoietic stem cell formation in response to blood flow
(Lundin et al., 2020).
The SynRAMTM 3D inflammation model from SynVivo uses
this barrier concept in a more complex chip design to study
real-time rolling, adhesion, and migration processes within a
microvasculature network. While simplified idealized networks
can be used to reproduce constant shear and flow conditions
from 0.05 to 0.4 Pa (Lamberti et al., 2013), a unique feature
of this chip is that network design can also be derived from
complex in vivo microvascular networks obtained from digitized
images (Figure 3D). This produces a vascular morphology
with converging and diverging bifurcations which result in
varying shear and flow conditions permitting the study of
inflammation and particle adhesion in a realistic and dynamic
environment (Rosano et al., 2009; Prabhakarpandian et al., 2011;
Lamberti et al., 2013). Indeed, the disruption to flow patterns
and morphology generated near to bifurcations within the chip
replicates increased adhesion of cells (platelets, leukocytes, etc.)
and particles observed at these sites in vivo under pathological
conditions (Prabhakarpandian et al., 2011).
Using OrganoPlate R© technology, Mimetas have created the
first high throughput blood vessel-on-chip system. Human
coronary artery endothelial cells seeded in the perfusion channel
proliferate to cover the surface forming a micro vessel with
a perfusable lumen (van Duinen et al., 2019). Fluid shear
(0.16 Pa) is applied to this system in a gravity-driven manner
to generate a bidirectional, oscillating flow rather than the
unidirectional linear flow observed in vivo. Crucially, the
tubular shape of this vessel only develops within the chip
when adherent endothelial cells are exposed to flow thus
highlighting the importance of biomechanical stimuli. This
system has been used to investigate drug delivery (Beekers
et al., 2018), angiogenesis (van Duinen et al., 2019) and to
explore the effects of inflammation on monocyte-to-endothelium
adhesion under flow (Poussin et al., 2020). In the latter,
adhesion of monocytic cells to endothelial microvessels is
observed in response to aerosols (Poussin et al., 2020) similar to
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what is observed in chip systems utilizing unidirectional flow
(Benam et al., 2016b).
Respiratory Models
Current models of the respiratory system typically focus on
the alveolus or airway epithelium. As the alveolus expands and
contracts during normal breathing the alveolar epithelium is
exposed to cyclic tensile strain while also receiving a low level
of shear stress due to air flow. Healthy epithelium typically
experiences up to 12% strain, however these levels can become
much higher in scarred areas which are less elastic (Waters
et al., 2012). The mechanical environment of the airway itself
is complex, while the contribution of strain is less, low level
circumferential and longitudinal expansion and contraction
will accompany normal breathing. This environment will be
greatly affected under diseased conditions such as asthma
where bronchoconstriction results in compressive loading of
the epithelium as the result of smooth muscle activation
(Tschumperlin and Drazen, 2001).
Few commercially available systems combine the ALI culture
required for these models with cellular stretching to incorporate
the tensile strain. The AXLung-on-a-chip, from AlveoliX is one
such system (Figure 3A), it replicates the alveolar barrier whereby
alveolar epithelial cells and endothelial cells are cultured in
tight monolayers upon either side of a thin, porous membrane
(Stucki et al., 2015, 2018). The inclusion of cyclic strain in this
model (10% strain, 0.2 Hz) influences the metabolic activity of
primary human pulmonary alveolar epithelial cells and increases
the permeability of the epithelial barrier with no effect on cell
layer integrity. Cytokine secretion by the epithelial cells is altered
by the inclusion of mechanics such that interleukin-8 release is
greater after 24–48 h of stretching relative to static conditions
(Stucki et al., 2015).
In the Alveolus chip from Emulate Inc., human or mouse
alveolar epithelial cells and endothelial cells are cultured
within the Chip-S1 on opposite sides of the PDMS membrane
described above (Figure 3B). The membrane is subjected
to cyclic stretch to represent physiological breathing (10%
strain, 0.2 Hz). This biomechanical input is essential for
the replication of lung function and results in a 10-fold
enhancement of the uptake of nano particulates into the alveolar
epithelium over static conditions dramatically increasing reactive
oxygen species production and promoting neutrophil capture
and transmigration (Huh et al., 2010). Pulmonary surfactant
production is enhanced within the chip further promoting
epithelium integrity and barrier function while functioning as
an important defense mechanism against bacterial infection
(Thacker et al., 2020). Several commercial systems have been
used to generate lung-on-a-chip models that mimic the complex
solid and fluid microenvironment of the airway epithelium
such as SynVivo’s SynALI lung model which comprises an
apical channel functionalized with lung epithelial cells and
surrounded by “vasculature” comprised of endothelial cells
separated by a porous scaffold (Kolhar et al., 2013; Liu
et al., 2019; Soroush et al., 2020). This structure allows the
formation of airway tubules through ALI culture within the
apical channel that transport mucus and are maintained by the
surrounding endothelium (Kolhar et al., 2013; Liu et al., 2019;
Soroush et al., 2020).
In the Airway-chip from Emulate Inc. primary human lung
airway basal stem cells are cultured under ALI on one side of the
membrane, while primary human lung endothelium is cultured
on the parallel vascular channel and exposed to continuous fluid
flow with a volumetric flow rate of 60 µL/h resulting in wall
shear stress of 0.0017 Pa (Huh et al., 2012; Jain et al., 2018).
The basal stem cells differentiate into a functional mucociliary
pseudostratified epithelium containing ciliated cells, mucus-
producing goblet cells, club cells, and basal cells in relevant in vivo
proportions. The underlying human pulmonary microvascular
endothelium forms a continuous cell monolayer linked by VE-
cadherin containing adherens junctions. This chip accurately
replicates viral infection by SARS-CoV-2 and influenza virus and
can be used to study the recruitment of circulating immune cells,
such as neutrophils, under dynamic flow to the site of infection.
In a recent study, this chip model successfully recapitulated
the effects of clinically used viral therapeutics for influenza
(Si et al., 2020).
Other systems combine ALI culture with flow to generate lung
models from tissue culture inserts such CNBio’s PhysioMimixTM
and Kirkstall’s Quasi Vivo system (Table 1). Mazzei et al.
(2010) have used the Quasi Vivo system to generate co-culture
models of lung epithelium and immune cells [dendritic cells
(DCs), macrophages]. In the QV600 system, lung epithelium
cultured on transwell inserts is subjected to ALI culture, which
coupled with perfusion accelerates development of the lung
epithelium with higher ciliogenesis, cilia movement, mucus-
production and improved barrier function relative to static
conditions (Chandorkar et al., 2017). In SynVivo’s SynALI model,
epithelial and endothelial co-cultures are grown in a tubular
structure to generate a central in vitro 3D hollow airway lumen
with continuous airflow which is flanked by two in vitro 3D
microvascular structures. The central lumen communicates via
pores to these vascular channels which are cultured with living
endothelium around a central lumen filled with fluid, mimicking
blood flow (Liu et al., 2019).
In recent work, Si et al. (2020) demonstrated that in the
Airway-chip from Emulate, only two of seven compounds
identified by drug repurposing screens in 2D culture systems
were effective at inhibiting viral entry of a pseudotyped SARS-
CoV-2 virus. These findings in the chip have been corroborated
by in vivo studies that similarly found one of these compounds,
amodiaquine and its active metabolite (desethylamodiaquine)
significantly reduced viral load in hamsters in both direct
infection and animal-to-animal transmission models of native
SARS-CoV-2 infection (Si et al., 2020). Thus, this study highlights
the enormous potential of OOC technology to screen drug
candidates more stringently prior to their use in animal
studies and thus accelerate both the development and rapid
repurposing of drugs.
Intestine Models
As part of normal gut function, the intestinal epithelium is
subjected to complex biomechanics. During peristalsis, waves
of highly synchronized contraction move digested food through
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the intestinal tract deforming the intestinal mucosal layer and
generating irregular compressive and tensile strains, and fluid
shear stress, which vary along the length of the digestive tract as
the viscosity of the digesta is altered (Brandstaeter et al., 2019).
The digestive system has been another key area of focus for
OOC technology as intestinal models are crucial for drug research
and development, providing platforms for drug adsorption,
efficacy and toxicity testing in addition to providing a range
of disease models for conditions including inflammatory bowel
disease and colitis.
The replication of peristaltic motions within the intestinal
microenvironment is key to generation of 3D tissue architecture
within organ-chips. The application of flow at 30 µL/h
(0.0346 mPa) and cyclic stretch (10%, 0.15 Hz) to the human
intestinal colorectal adenocarcinoma cell line (Caco-2) cultured
in Emulate’s Chip-S1 (Figure 3B) promotes formation of a
columnar epithelium which spontaneously grows into folds
recapitulating the structure of intestinal villi (Kim et al., 2012;
Grassart et al., 2019). This platform can support the co-
culture of intestinal microbes for extended periods without
compromising epithelial viability (Kim et al., 2012). Moreover,
it is compatible with human organoid culture such that organ
chips representing small intestine (Kasendra et al., 2018), adult
duodenum (Kasendra et al., 2020) and colon (Sontheimer-Phelps
et al., 2020) have been successfully generated in combination
with co-cultures of intestine-specific endothelium. For the colon
chip in particular, the use of this technology to generate
a continuously perfused culture at 60 µL/h (∼0.0692 mPa)
supports accumulation of a mucus bilayer with impenetrable and
penetrable layers, and a thickness similar to that observed in the
human colon which can be analyzed non-invasively in real time
(Sontheimer-Phelps et al., 2020).
In Micronit’s gut-on-chip model, Caco-2 cells are subjected
to flow at 100 µL/h producing a shear stress of ∼0.02–
0.17 mPa at the cell surface (Kulthong et al., 2020). Following
culture in this manner for 21 days, caco-2 cells form a
continuous epithelium with greater height than equivalent
transwell cultures that have an enhanced barrier function. Caco-
2 cell differentiation was comparable with static cultures in this
model (Kulthong et al., 2020).
In Mimetas’ 3-lane Organoplate R©, perfused intestinal tubules
can be cultured in a high throughput manner as a mono-
culture or co-culture with immune cells or blood vessels and
stromal tissue to generate a model of the intestinal epithelium
(Trietsch et al., 2017). The inclusion of stromal tissue interactions
is an important factor for replicating physiological cellular
interactions. In this system, Trietsch et al. (2017) cultured Caco-
2 cells against an ECM gel, which proliferate upon application
of bi-directional flow to form a confluent tube. Perfusion is
critical for tubule formation. Beaurivage et al. (2019) have
recently used this model to mimic the effects of Escherichia
coli-activated DCs on the intestinal epithelium. Through the
addition of a cytokine cocktail of IL-1β, tumor necrosis factor
α (TNF-α) and interferon-γ (IFN-γ), they were able to replicate
the loss of barrier function observed in irritable bowel disease
(Beaurivage et al., 2019). Similar results were achieved using
iPSCs which can be induced to undergo differentiation within
the Organoplate R© to express mature intestinal markers, including
markers for Paneth cells, enterocytes and neuroendocrine cells
(Naumovska et al., 2020).
In addition to drug efficacy, biomechanics can also mediate
pathogen infectivity. In the small intestine, the incorporation of
both fluid flow (30 µL/h, fluid shear: 0.346 mPa) and tensile
strain (10%, 0.15 Hz) mimicking peristalsis promotes formation
of a more physiologically relevant 3D architecture. Grassart
et al. (2019) observed that these mechanically active intestine
chip cultures better replicate bacterial infection uncovering
a mechanism whereby Shigella flexneri exploits the epithelial
crypt microarchitecture and active biomechanics to efficiently
invade the intestine. In the region of 70% of all drugs are
administered orally (Brandstaeter et al., 2019). Their processing
and effectiveness depend crucially on gastric mechanics thus
the incorporation of active biomechanical stimuli into OOC gut
models is essential to the successful use of this technology.
Kidney Models
Several OOC models have focused on the kidney proximal
tubule as the site at which active clearance, reabsorption,
intracellular concentration, and local interstitial accumulation
of drugs primarily occurs. The epithelium in this region is
continually exposed to shear stress in the region of 0.02 Pa as the
result of constant flow of the glomerular filtrate which influences
cell morphology causing alignment and elongation of kidney
epithelial cells in the direction of flow (Vriend et al., 2020), and
modulates expression of apical and basolateral transporters and
sodium transport (Duan et al., 2010).
Nephrotoxicity is a major cause of drug attrition during
pre-clinical pharmaceutical development and is responsible for
almost 20% of failures during Phase 3 clinical trials underlying
the limitation of current methodologies (i.e., 2D cell culture and
animal models) to predict the human response. The inclusion of
biomechanical stimuli in kidney models examining drug toxicity
is essential as exemplified by the use of both the OrganoPlate R©
(Mimetas) and Chip-S1 (Emulate) systems which show that both
albumin uptake and drug efflux are enhanced in response to
fluid shear stress despite the differential use of uni-directional
and bi-directional flow in these models (Jang et al., 2013; Vriend
et al., 2020). Jang et al. (2013) report that cisplatin toxicity
more closely replicates the in vivo response observed than
traditional culture techniques. Thus, the use of these models
which incorporate biomechanics to screen for kidney injury early
in the drug discovery process will provide greater capacity to
predict responses in humans.
Musculoskeletal Models
The nature and magnitude of biomechanical stimuli experienced
by the musculoskeletal system are highly varied both between
connective tissue types and within them due to the extreme forces
that must be endured during physical activity. These mechanical
stimuli are essential to the health and maintenance of the tissue;
regulating cell morphology, proliferation matrix production and
catabolism. Articular cartilage is routinely exposed to diverse
mechanical stimuli consisting of compressive, shear and tensile
strains as well as associated alterations in fluid shear and
osmolality as a result of normal physical activity (Knecht et al.,
2006). Energy-storing tendons like the Achilles are designed
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to stretch and recoil to increase efficiency during locomotion
and are thus subjected to high magnitude stresses and strains
during exercise. In the bone, oscillatory fluid flow generated
by compressive loading generates shear stress in the lacunar-
canalicular network which influences both the maintenance
and healing of bone tissue and is essential for bone health.
Inappropriate cellular responses to these stimuli result in the
disruption of tissue homeostasis and can lead to conditions such
as tendinopathy and osteoarthritis (Felson, 2013; Dean et al.,
2017). Thus, the incorporation of biomechanical stimuli into
OOC models of the musculoskeletal system is essential. However,
few commercial systems have been used to develop models in
this field to date.
Existing models from Emulate, Micronit and TissUse have
focused on bone or bone marrow while models for muscle,
cartilage or tendon are overlooked. This is likely due to the
difficulty in replicating the complex architecture of these tissues
and the more dynamic biomechanical environment the cells
experience. A bone-on-a-chip generated using Emulate’s Chip-
S1 (Figure 3B) utilizes an inducible, MSC-bone morphogenic
protein-2 (BMP-2) overexpression system cultured on one side
of the membrane to examine osteogenic differentiation under
flow (Sheyn et al., 2019). In this system, cells grown on Bone-
chips under flow (30 µL/h, shear stress: 0.346 mPa) showed
enhanced survival and proliferation relative to cells grown under
static conditions. MSCs cultured in this manner exhibited greater
expression of the osteogenic markers osteopontin, bone sialo-
protein, and collagen type I, despite the use of constant flow in
this system (Sheyn et al., 2019).
Hydroxyapatite coated zirconium oxide scaffolds
incorporated within the multiorgan chip (MOC) from TissUse
combine tissue engineering techniques with OOC technology
and have been used to generate bone-marrow-on-chip (Sieber
et al., 2018). In this model, a cell seeded scaffold of MSC and
multipotent haematopoietic stem and progenitor cells (HSPC)
is cultured within the MOC which comprises two separate
independent channel circuits, each hosting a single culture
compartment interconnected by the channel system. One of
these compartments is used for the cell scaffold, while the other
functions as a medium reservoir. The flow rate (5 µL/min) is
controlled by an on-chip peristaltic micro pump (frequency
of 2 Hz for continuous dynamic operation) integrated into
each circuit (Sieber et al., 2018). Long term culture of HSPCs
is maintained in the MOC for a period of 28 days. The cells
form a microenvironment reminiscent of the in vivo bone
marrow niche within the scaffold, and remain in their primitive,
undifferentiated state (Sieber et al., 2018).
PERSPECTIVES
Challenges Associated With
Incorporating Biomechanical Stimuli in
OOC Models
Incorporating appropriate physiologically representative
biomechanical stimuli into OOC models is challenging. A major
confounding factor in the replication of in vivo biology is tissue
structure. Cells within their native environment can withstand
significantly higher levels of mechanical stimulation due to the
structural organization of the tissue. For example, joint loading
during physical activity subjects articular cartilage to forces
several times greater than body weight. However the unique
anisotropic structure of this tissue (depth dependent variation
in collagen fibril alignment and confinement of hydrated
proteoglycan) allows these forces to be dissipated such that
the cellular strains experienced by chondrocytes are actually
much lower (Bergmann et al., 1993). Thus, further integration
of OOC technology with tissue engineering techniques such
as 3D bioprinting to achieve structurally aligned matrices or
generate 3D scaffolds within chips, has the potential to create
better representations of the mechanical environment within
organ models. This could unlock new application areas for OOC,
such as modeling fibrosis and tumor stroma.
The successful recapitulation of the in vivo biomechanical
environment will also be dependent upon the ability of organ
chips to incorporate multiple forms of mechanical stimuli
within a single device. Thus far commercial systems have
achieved the integration of stretch and flow (Emulate Inc.,
BI/OND; Figures 1A,B,D). However, to date no commercial
systems are available which apply compression in organ
chips. The incorporation of compressive strain into OOC
systems will be essential to the development of multiple
models particularly those mimicking the musculoskeletal system.
Topography and geometric confinement (Figures 1G,H) provide
two biomechanical cues which while not yet incorporated into the
above reviewed commercial systems, could be easily integrated
into future iterations of these to build biomechanical complexity.
Moreover, integrating these stimuli into a single model presents
significant technical challenges both in terms of the interactive
effects these stimuli will exert upon each other (e.g., flow rate
changes as the result of stretch induced changes in channel
volume and shape) and the increased complexity of the biological
outcome. To replicate the body’s fluid shear conditions more
accurately, organ chips should feature greater ranges of fluid
shear levels and more variable types of flow such as oscillatory
or pulsatile flow. Once again, the successful integration of these
stimuli will enhance the accuracy of organ models and thus better
replicate tissue function in health and disease.
A caveat to increasing the biological complexity of these
models is the conflict this represents with analytical requirements
such as real-time imaging, sampling, and scaling to increase
throughput. Moreover, more complex models will likely produce
more complex outputs due to additional cellular and matrix
interactions which could be difficult to interpret.
One of the many advantages of OOC systems are that they
have the potential to be accessible in ways that cannot easily be
achieved in vivo. Thus, the ability to culture cells for extended
periods with regular sampling of culture media and cellular
by-products are a necessary feature. Mechanical stimuli within
OOC systems could also be used more generally to improve
mechanobiological studies. Therefore, researchers must be able
to monitor both the cells and their responses in real-time in a
non-destructive manner using existing research methodologies
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for this technology to be adopted more readily. At the same
time, for these systems to be successful within the pharmaceutical
industry, they need to be high throughput and have the
potential for significant automation of downstream analyses. This
undoubtedly presents significant technical challenges relating to
the development of robust standardized equipment supporting
these organ chips for the application of multiple types of stimuli
at consistent, and tightly controlled levels.
The use of OOC technology for diagnostic approaches
or to deliver personalized medicine is highly attractive. The
incorporation of this technology into clinical practice to
determine drug responsiveness of patient samples and inform
clinical decisions means that these models must be established
in a highly standardized manner and subjected to well-defined
mechanical input to deliver clear outcomes.
How Much Mechanobiology Do We
Need?
Organ-on-chip models incorporating active mechanical stimuli
have arrived at similar findings demonstrating the crucial role
of biomechanics in replicating in vivo behavior and dictating
drug response. In this review, we identify several studies
demonstrating that incorporation these stimuli into OOC models
has the potential to create more sophisticated organ models
that better represent the in vivo scenario. In vascular models,
appropriate modulation of inflammatory responses is observed
at shear stress levels far below those found in vivo (Benam et al.,
2016a,b; Poussin et al., 2020). In the airway, stretch influences
viral entry and drug efficacy (Si et al., 2020). In the kidney,
the application of apical shear stress modulates drug uptake
and nephrotoxicity (Duan et al., 2010; Vriend et al., 2020).
While in the intestine, the inclusion of peristalsis-like stretch
creates a more accurate representation of bacterial infection
(Grassart et al., 2019).
These examples from different organ systems provide strong
evidence to support the consideration of mechanobiology when
designing in vitro OOC model systems to obtain a more accurate,
reliable prediction of the human response prior to clinical trials.
Ultimately, this will accelerate the drug development process by
both identifying potential drug candidates earlier in the pipeline
and by ruling out many of those that will fail in subsequent
clinical trials. However, none of these models precisely mimic
the entire in vivo biomechanical environment, rather focusing
on a key stimulus delivered at approximately physiological
intensities. These systems also do not account for pathological
patient-specific biomechanics which typically deviate from what
is considered physiologically normal and may be important in the
use of OOC for personalized medicine. This begs the question,
how accurately do biomechanical stimuli need to be replicated?
Several commercial systems already incorporate a sufficient
level of biomechanical stimulation to modulate drug efficacy in
multiple organ models and are beginning to be adopted by the
pharmaceutical industry in their current forms. The requirement
for standardized systems suggests future research should focus on
developing the biology within these existing systems. Validation
of these OOC systems in a clinical context requires the replication
of in vivo human biology, which must provide the benchmark
when considering the extent to which mechanical stimuli should
be incorporated. A greater understanding of how individual
forms of biomechanical stimuli influence cell behavior in both
health and disease is therefore required to develop these models
and enhance their ability to predict drug performance in humans.
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